WESTBOROUGH, Mass., Dec. 4 /PRNewswire/ -- Informa Life Sciences has announced that the Third Annual Pharmaceutical Achievement Awards will take place during a black-tie event on the eve of August 8, 2004, kicking off the first day of the Drug Discovery Technology(TM) World Congress which takes place every August in Boston. The Pharmaceutical Achievement Awards will support the pharmaceutical and biotech industries by recognizing excellence by both organizations and individuals in a wide range of important disciplines. This program is the result of a broadly supported, unbiased effort that reflects the contributions of fourteen separate pharmaceutical entities, a well-respected international accounting firm and the production team of Informa Life Sciences.
The award categories are made up of a set of thirteen high-level awards that will honor industry and individual achievements in drug discovery, community involvement and corporate governance. Honorees will be determined through a comprehensive international nomination process and winners selected by a cross-industry, fourteen-person Executive Review Board.
The nomination process has begun and will continue until March 30, 2004 in the following award categories:
Scientific Achievement: Lifetime Achievement Award Chief Scientific Officer of the Year Academic Scientist of the Year Worldwide Health and Community Involvement: Good Citizen Award Award for Advancement in the Cause of Worldwide Health Award for Disease Prevention and Education Drug Compound Research and Development: Cardiovascular Compound of the Year Central Nervous System Compound of the Year Inflammation and Immunology Compound of the Year Oncology Compound of the Year Pharmaceutical Business: Pharmaceutical Executive of the Year Merger & Acquisition Deal of the Year Licensing Deal of the Year Nominations for the event will only be accepted online: http://www.pharmawards.com/ Executive Review Board: Linda Alcorn, Esq., Director, Sterne, Kessler, Goldstein & Fox Frank Bennett, Ph.D., Vice President of Biology, Isis Pharmaceuticals Peter Corr, Ph.D., Senior Vice President, Pfizer Global Research and Development Linda Alcorn, Esq., Sterne, Kessler, Goldstein & Fox J. Michael French, Entelos Don Halbert, Ph.D., Abbott Laboratories Jeffrey Hanke, Ph.D., AstraZeneca R&D Boston Sangtae Kim, Ph.D., Purdue University Henry B. Lowman, Ph.D., Genentech Ron Magolda, Ph.D., Wyeth Adam Smith, Nature Publishing Group Peter F. Smith, Ph.D., Millennium Pharmaceuticals Phillip Tagari, MA, Amgen, Inc. Gregory Tsongalis, Ph.D., Hartford Hospital Martin Wasserman, Ph.D., Atherogenics Contact: Abby Votto Informa Life Sciences Group Tel: 508 614-1404 Fax: 508 616-5533 Email: avotto@ibcusa.comhttp://www.pharmawards.com/
Informa Life Sciences Group
CONTACT: Abby Votto, Informa Life Sciences Group, +1-508-614-1404,avotto@ibcusa.com